Drug
Rdx5791
Rdx5791: highest development phase Phase 2, developed by Ardelyx. 3 trial records tracked on RxWires.
- Highest phase
- Phase 2
- Developer
- Ardelyx
Trials
| Drug | Phase | Indication |
|---|---|---|
| RDX5791 NCT01340053 | Phase 2 | Constipation Predominant Irritable Bowel Syndrome |
| RDX5791 NCT02796131 | Phase 1 | Healthy |
| RDX5791 NCT02819687 | Phase 1 | Healthy |
Latest
No recent events.
Follow Rdx5791 on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.